Deltec Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Deltec Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-70,468	Closed	-$156K	–	188
2023 Q2	$156K	Buy	+70,468	New	+$146K	0.03%	152

Deltec Asset Management's PRTK Position: Q3 2023 in Review

Deltec Asset Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 70,468 shares — an estimated $156K sold.

Deltec Asset Management first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $156K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Deltec Asset Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Deltec Asset Management sold 70,468 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $156K.
Deltec Asset Management first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
Deltec Asset Management's Paratek Pharmaceuticals, Inc. position peaked at $156K in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Deltec Asset Management's 13F filing for Q3 2023, filed 23 Oct 2023.